[1]
2025. Preclinical Use of Group I Metabotropic Glutamate Receptors (Group I mGluRs) for Ischemic Stroke: Systematic Review and Meta-Analysis. American Journal of Medical Science and Innovation. 4, 2 (Nov. 2025), 118–126. DOI:https://doi.org/10.54536/ajmsi.v4i2.6056.